and/or

932 Blog posts found

In the Lab

Gene Mutation Linked to Aggressive Form of Sarcoma Affecting Children and Young Adults

A newly discovered gene mutation appears to be the driving force behind a particularly aggressive form of embryonal rhabdomyosarcoma, a rare cancer of the skeletal muscle.

Pictured: Marc Ladanyi

Q&A

Should the Elderly Consider Colon Cancer Screening?

Memorial Sloan Kettering investigator Ann Zauber answers questions about the risks and benefits of colon cancer screening in the elderly.

In the Clinic

Transplantation Shown to Be Highly Effective in Treating Severe Combined Immunodeficiency

A study shows that treatment of severe combined immunodeficiency (SCID) with stem cell transplantation is very effective, especially if done early.

Pictured: Richard O’Reilly

Memorial Sloan Kettering’s Head and Neck Service Celebrates 100 Years

View highlights from the opening ceremony of the Fifth World Congress of the International Federation of Head and Neck Oncologic Societies, which included opening remarks from Bill Clinton and a keynote speech from Michael Douglas.

Pictured: Jatin Shah and Michael Douglas

In the Lab

Compound from Tropical Plant Targets Key Cancer-Causing Genes

Memorial Sloan Kettering researchers have found a naturally occurring compound that can destroy cancer cells in mice by targeting MYC, a cancer-causing gene that has remained elusive until now.

Feature

Spotlight on Dermatology Nursing

Today, we spotlight our dermatology nurses. Learn more about them.

Pictured: Anna Skripnik & Kathryn Ciccollini

In the Clinic

Study Shows Robotic Surgery Holds No Major Advantages for Bladder Cancer Patients

Memorial Sloan Kettering researchers have found that the use of surgical robots does not lead to better outcomes in patients undergoing radical cystectomy for bladder cancer, bringing into question the added costs of the tools.

Pictured: Robotic surgery

Q&A

Five Questions for Sarcoma and Melanoma Expert Mark Dickson

In this Q&A and video, medical oncologist Mark Dickson discusses his approach to treating sarcoma and melanoma and how he develops individual treatment plans for each patient.

Finding

Hsp90: A Very Promising Target for Cancer Therapy

A small molecule discovered at MSK called PU-H71 blocks the growth of cancer cells and enables doctors to image tumors.

Pictured: Gabriela Chiosis

Slideshow

Memorial Sloan Kettering Celebrates 130 Years of Progress

Memorial Sloan Kettering celebrates 130 years of tremendous progress in our quest to eradicate cancer.